Clorox Co (CLX)
134.84
-1.43 (-1.05%)
NYSE · Last Trade: May 19th, 11:54 PM EDT
Consumer products giant Clorox (NYSE:CLX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 8% year on year to $1.67 billion. Its non-GAAP profit of $1.45 per share was 6.9% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
Via The Motley Fool · May 11, 2025
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.
Via Chartmill · May 6, 2025
Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting.
Via Benzinga · May 6, 2025
Household products company Spectrum Brands (NYSE:SPB)
will be announcing earnings results this Thursday before market open. Here’s what you need to know.
Via StockStory · May 6, 2025
Pet company Central Garden & Pet (NASDAQ:CENT)
will be reporting results tomorrow after market close. Here’s what investors should know.
Via StockStory · May 6, 2025
For fiscal 2025, Clorox guided for sales down 1% to flat, compared to its previous outlook of down 1% to up 2%
Via Stocktwits · May 6, 2025
Consumer products giant Clorox (NYSE:CLX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 8% year on year to $1.67 billion. Its non-GAAP profit of $1.45 per share was 6.9% below analysts’ consensus estimates.
Via StockStory · May 5, 2025
Clorox releases its third-quarter results after Monday's closing bell. Here's a look at the key figures from the report.
Via Benzinga · May 5, 2025
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top S&P500 gainers and losers in today's after hours session.
Via Chartmill · May 5, 2025
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services sector, raising doubts about near-term rate cuts and weighing on risk appetite.
Via Benzinga · May 5, 2025
Consumer products giant Clorox (NYSE:CLX)
will be reporting results tomorrow after the bell. Here’s what investors should know.
Via StockStory · May 4, 2025
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Via StockStory · April 29, 2025
Clorox trades at $138.60 per share and has stayed right on track with the overall market, losing 12.8% over the last six months while the S&P 500 is down 8.1%. This may have investors wondering how to approach the situation.
Via StockStory · April 24, 2025
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Via StockStory · April 23, 2025
Stock market expert Jon Erlichman recently shared a review of stock returns during the last six U.S. recessions, highlighting those that have performed well in difficult times.
Via Benzinga · April 19, 2025
The S&P 500 is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · April 16, 2025
These companies are on their way to becoming Dividend Kings.
Via The Motley Fool · April 4, 2025
The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as “Buying Dividends” or “Dividend Capture.”
Via Talk Markets · March 25, 2025